Follow the people · Insider
Rehan Verjee
Rehan Verjee files insider transactions with the SEC as a director of Tyra Biosciences. We hold 1 disclosed purchase or sale filed since 15 June 2022, 1 of them in the last 90 days.
- Files forTYRA
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure11 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 June 2022 — 9 September 2026Director · Tyra Biosciences 6 Form 4 lines · source: SEC Form 4
Every transaction
6 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | bought on the open market | Tyra Biosciences | 972 shares | up +0.1% | up +0.0% |
| 28 May 2026 | 1 Jun 2026SEC Form 4 | 4 d | was grantednot a trade | Tyra Biosciencesderivative | 13,160 shares | down −32.6% | down −27.5% |
| 29 May 2025 | 2 Jun 2025SEC Form 4 | 4 d | was grantednot a trade | Tyra Biosciencesderivative | 22,200 shares | up +138.2% | up +129.5% |
| 29 May 2024 | 31 May 2024SEC Form 4 | 2 d | was grantednot a trade | Tyra Biosciencesderivative | 18,600 shares | up +38.2% | up +35.8% |
| 31 May 2023 | 2 Jun 2023SEC Form 4 | 2 d | was grantednot a trade | Tyra Biosciencesderivative | 14,500 shares | up +52.2% | up +51.6% |
| 13 Jun 2022 | 15 Jun 2022SEC Form 4 | 2 d | was grantednot a trade | Tyra Biosciencesderivative | 14,500 shares | up +309.5% | up +274.7% |
Both percentages are the stock’s move, not Rehan Verjee’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 6 of the 6 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.